Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bisphosphonates for Prevention of Post-Denosumab Bone Loss in Premenopausal Women With Idiopathic Osteoporosis

NCT03396315 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT03396315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03396315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bisphosphonates for Prevention of Post-Denosumab Bone Loss in Premenopausal Women With Idiopathic Osteoporosis
Lead sponsor
Columbia University
Phase
Phase 2
Overall status
Completed
Start date
January 29, 2018
Completion date
June 9, 2023
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

iop, osteoporosis